Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Moderna Inc
Recent news which mentions Moderna Inc
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
FDA may pull authorization of Pfizer’s Covid vaccine for children under 5
August 12, 2025
Tags
US: News
Biotechnology
Health & Science
From
CNBC.com News
Moderna cuts high end of 2025 revenue outlook on vaccine shipment delay in U.K.
August 01, 2025
Tags
Biotechnology
US: News
Breaking News: Business
From
CNBC.com News
Moderna to slash 10% of workforce as biotech cuts costs, Covid shot sales slow
July 31, 2025
Tags
Health & Science
Breaking News: Business
Biotech and Pharmaceuticals
From
CNBC.com News
Pandemic darlings Moderna, BioNTech are now on two different paths
July 31, 2025
Tags
Biontech SE
Moderna Inc
Health care industry
From
CNBC.com News
Healthy Returns: Researchers move closer to a universal cancer vaccine
July 23, 2025
Tags
Healthy Returns
Teladoc Health Inc
Merck & Co Inc
From
CNBC.com News
Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot
June 30, 2025
Tags
Biotech and Pharmaceuticals
Breaking News: Business
Novavax Inc
From
CNBC.com News
RFK Jr.'s firing of CDC vaccine advisors 'circumvents science' and could threaten public health, experts say
June 10, 2025
Tags
Pfizer Inc
Business
Biontech SE
From
CNBC.com News
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
June 09, 2025
Tags
GSK plc
Business
Pfizer Inc
From
CNBC.com News
Healthy Returns: RFK Jr.’s Covid vaccine recommendation change could threaten health, access
May 28, 2025
Tags
Hinge Health Inc
Biotech and Pharmaceuticals
Health & Science
From
CNBC.com News
Healthy Returns: Novavax scores narrower Covid vaccine approval after delay
May 20, 2025
Tags
Moderna Inc
Health care industry
Social issues
From
CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
Tags
GSK plc
Gilead Sciences Inc
Breaking News: Markets
From
CNBC.com News
Vaccine stocks fall after key FDA official resigns in protest of RFK Jr.
March 31, 2025
Tags
Biotech and Pharmaceuticals
Jyong Biotech Ltd
Pfizer Inc
From
CNBC.com News
Most of the S&P 500 is already in correction territory as benchmark teeters near milestone
March 11, 2025
Tags
Investment strategy
Enphase Energy Inc
Breaking News: Investing
From
CNBC.com News
OpenAI tops 400 million users despite DeepSeek's emergence
February 20, 2025
Tags
Moderna Inc
Economy
Morgan Stanley
From
CNBC.com News
Moderna beats on revenue but loses more than expected as it scales down manufacturing
February 14, 2025
Tags
Earnings
Breaking News: Business
Biotech and Pharmaceuticals
From
CNBC.com News
Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary
February 04, 2025
Tags
Health & Science
US: News
Biotechnology
From
CNBC.com News
5 things to know before the stock market opens Friday
January 24, 2025
Tags
Business
Politics
Investment strategy
From
CNBC.com News
A norovirus vaccine could be on the horizon as cases rise
January 23, 2025
Tags
Biotech and Pharmaceuticals
Health & Science
Business News
From
CNBC.com News
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
January 14, 2025
Tags
Waystar Holding Corp
Moderna Inc
Health care industry
From
CNBC.com News
5 things to know before the stock market opens Tuesday
January 14, 2025
Tags
Earnings
Caterpillar Inc
UnitedHealth Group Inc
From
CNBC.com News
Moderna stock plunges 18% after company lowers 2025 sales forecast by $1 billion
January 13, 2025
Tags
Business
Novavax Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Nvidia, Palantir, Ionq, Novavax, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
January 07, 2025
Tickers
EVS
IONQ
MRNA
NEWS
Tags
Shivdeep Dhaliwal
Market News
NVDA
From
Benzinga
S&P 500, Nasdaq-100 are getting an update. Trillions depend on who’s in and who’s out
December 20, 2024
Tags
Palantir Technologies Inc
Qorvo Inc
Investment strategy
From
CNBC.com News
Super Micro slides 7% after stock is dropped from Nasdaq 100
December 16, 2024
Tags
Breaking News: Technology
Technology
Palantir Technologies Inc
From
CNBC.com News
Executives seek more protection after UnitedHealthcare CEO Thompson killing, Kroll says
December 05, 2024
Tickers
LAW
LAWS
Tags
Walgreens Boots Alliance Inc
Breaking News: Politics
National security
From
CNBC.com News
Cramer says an RFK Jr.-run HHS ultimately won't tank junk food and drug industries
November 15, 2024
Tags
U/S/ Markets
PepsiCo Inc/
THE JM SMUCKDRN
From
CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
November 14, 2024
Tags
Five Below Inc
Groupon Inc
JD/Com Inc
From
CNBC.com News
Vaccine maker stocks fall on reports Trump plans to tap RFK Jr. to lead HHS
November 14, 2024
Tags
Health & Science
Biotechnology
US: News
From
CNBC.com News
Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take hold
November 07, 2024
Tags
Health & Science
Biotech and Pharmaceuticals
Earnings
From
CNBC.com News
Trump says he will give RFK Jr. a major health role if he wins the White House. Here's what that means for patients, drugmakers
November 05, 2024
Tags
Biotech and Pharmaceuticals
Health & Science
Biotechnology
From
CNBC.com News
< Previous
1
2
3
4
5
6
7
8
9
...
21
22
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.